Image: Daniel Huizinga

Cannabis Lobbying Spend Bounces Back

Lobbying spending by cannabis-focused entities declined after a Q4 2019 peak that coincided with the passage of the SAFE Banking Act. But this quarter, spending has rebounded.

Lobbying
New York

New York’s Cannabis Equity Fund Recalibrates: “The Markets Have Changed” 

Cannabis regulators met on Tuesday for the second time in May to also approve emergency enforcement rules and a settlement related to a lawsuit that blocked licensing in parts of the state.

Regulation

As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.